Business Context and Reporting Period
Company: Collegium Pharmaceutical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 10, 2016
Reporting Period: Quarterly period ended June 30, 2016
This filing serves as a notification that the company issued a press release on August 10, 2016, announcing its financial results for the quarter ended June 30, 2016. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K and does not contain specific financial data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. This information is expected to be detailed in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 10, 2016) for actual revenue, net loss, and cash position figures.
- Verify the company's cash runway and burn rate as disclosed in the press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm if there were any material changes in debt obligations or equity financing activities during the quarter.